Member Info for comek2

“Omicron spreads faster and weakens vaccine efficacy, WHO says”

Just out now, the Independent https://apple.news/AEtE_1fnxQVCA1Zi_unm-YQ

The rns of 29 September states the 1st sale of AIHL test to be expected in autumn. This week is the last of autumn, so could drop any day now really.

Note latest government covid guidelines, rapid test to be given daily even to those vaccinated if in contact with infected people. Plus unvaccinated must isolate. Therefore gdr cop will solve all these problems that neither lft nor prc will, as gdr’s has the efficacy of PCR test and is more rapid than lateral flow test. So it’s very possible approval by HMRA of gdr poc be speeded up to meet the challenges.

“Fully vaccinated people in England who have had contact with someone with Covid-19 should take a rapid lateral flow test every day for seven days, in an effort to slow the spread of the virus, the Department of Health and Social Care has said.”

“Unvaccinated adults must continue to self-isolate for 10 days if they have contact with someone with Covid-19.”

“Dr Jenny Harries, the head of the UK Health Security Agency, said: “If you are identified as a contact of someone with Covid-19, taking a rapid daily test – and only needing to isolate if it is positive – will help reduce the spread of the virus and minimise its impact on our everyday lives over the coming weeks and months. Rapid tests are freely available in pharmacies and online.”

https://www.theguardian.com/world/2021/dec/12/vaccinated-contacts-of-people-with-covid-told-to-test-daily-for-a-week

“Scientists from the London School of Hygiene and Tropical Medicine (LSHTM) also warned that Omicron, first discovered in southern Africa, is likely to be the dominant coronavirus variant by the end of the month.”

Dr Nick Davies, from LSHTM’s Centre for Mathematical Modelling of Infectious Diseases, who co-led the research, said on Saturday: “These are early estimates, but they do suggest that, overall, Omicron is outcompeting Delta rapidly by evading vaccines to a substantial degree.
“If current trends continue, then Omicron may represent half of UK cases by the end of December.”

https://www.theguardian.com/world/2021/dec/11/omicron-covid-variant-could-cause-75000-deaths-in-england-by-end-of-april-say-scientists

“Daily test and pub passports are being considered as data shows boosters are key against Omicron.”

“Fresh Covid rules are being considered by ministers after they were told that two vaccine doses offer little protection against catching the Omicron variant.”

“Contacts of known cases are likely to have to test themselves every day to prevent a huge surge in infections over Christmas. Scientific advisers also want people to prove that they are negative for coronavirus before going to public places. The Omicron variant is likely to account for most cases of Covid in Britain within the next two weeks and scientists fear that the scale of infections could overwhelm the NHS even if most cases are mild.”

https://www.thetimes.co.uk/article/new-covid-restrictions-to-slow-spread-of-omicron-variant-mp0rnqwlk

Just out now, HuffPost

“Emergency Cobra Meeting On Covid-19 This Afternoon
Michael Gove is to host the meeting with leaders of the devolved nations.”

https://apple.news/AMjxQwNLbTu-r_RSuS7Ilgw

1 working day for us investors to get an rns by Monday = 4 days for gdr to sign commercial partners. A very good bet in favour of investors; you won’t get that in a betting shop, lol

They’re 1000 private companies providing Covid testing on the government website. You bet they will be falling over themselves to get hold of gdr 7.5/17 minutes poc, as theirs are 24-48 hours at the moment.

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039577/covid-private-testing-providers-general-testing-091221.csv/preview

“Chaos at Gatwick quarantine hotel after fire alarm sparks mayhem”, the evening standard just now.

https://apple.news/A1P6W82hLT4qWgUmZ9ykaFg

With gdr poc test no need for hotel quarantine, saves everyone money.

Sorry, should read it detect Omicron even without the “S gene”.

‘But in addition, genomic testing had discovered cases where there had been a “S gene drop-out” in the virus – a proxy for likely Omicron.’

The evening standard just now,

https://apple.news/AoJybbZgVTdaQwnuh4sUFHw

That makes the current PCR of not much use and GDR test the only one so far since it detects the “S gene” 100%. Not to mention the cheapest, fastest and poc for venues, airlines, cruse liners etc….and of course care homes, hospitals and businesses.

Surely you don’t want take over from this price do you, sherwood?

You’ve got to take away 8p (12%) from the current showing sp as it closed at 71p and corrected at open. So it’s up ONLY 6p (11%) at time of writing. So plenty to go yet.

This week is going be very good for most Covid stocks and I think gdr will be the best of them, given the low free float, small mcap and a mass scale test of only 7.5 minutes targeting the European market where the situation continues to deteriorate rapidly. GL

The Organisation for European Economic Co-operation (OEEC) consider the LAMP Covid test to have many advantages over PCR, because of low cost, quick results, and more appropriate for mass testing. The only downside LAMP has, or rather had (the article is a year old) was lower sensitivity ie 70% which they believe can be overcome.Indeed GDR has overcome the sensitivity issue, reaching 98.2%.

https://www.oecd.org/coronavirus/policy-responses/testing-for-covid-19-how-to-best-use-the-various-tests-c76df201/

They even suggest their appropriateness for airlines. With the reintroduction of travel testing from Tuesday for the UK which most European countries never abandoned, this can only be good news for GDR. Plus GDR targeting European markets is a perfect timing giving the dire Covid situation throughout Europe with near lockdowns and draconian restrictions imposed on many countries over the last few days. This week should see similar last week sp rise from the expected news, eg hearing loss commercial contract due this autumn, CE mark, followed by 1 or more commercial contracts/tie up as per last Monday rns.

The health minister last night point to diagnostic tests over this winter; gdr poc is at the right time and hopefully at the right place.

https://www.youtube.com/watch?v=0ggtj-CdUIE

Bring back ‘work from home’ guidance to tackle omicron, top advisers tell government

https://www.independent.co.uk/news/uk/politics/covid-omicron-work-from-home-b1969592.html

Therefore, gdr POC 7/17 minutes test should be the answer as it allows business to have staff tested on the premises, not to mention the nhs for quicker results compared to the current PCR.

“A top Federal Reserve official has warned that the Omicron coronavirus variant threatens to fuel soaring inflation in the US by putting further pressure on supply chains and worsening worker shortages.”, Financial Times 2 hours ago.

Great find. Don’t think all these happenings are a coincidence. Todays options coming after Monday’s rns pointing to next week CE and commercials partners already interested and looking at our test and now a sales executive job advertised. Indeed because they fxxed up with sales previously, they wouldn’t advertise for this job if nothing was already in the pipeline as implied in Monday rns.

Great motivational options at 31p. Sure they would want to sell at much higher price and only get them if they reach performance:

genedrive plc
("genedrive" or the "Company")

Grant of Options

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that on 2 December 2021 share options ("Options") were granted to members of its senior management team to acquire a total of 400,000 ordinary shares of 1.5p each ("Ordinary Shares") in the Company under the Company's Share Option Scheme.

The Options have been granted with an exercise price of 31p being equal to the closing price on the day before the grant and vest after a period of three years, subject to certain performance criteria being met through achieving revenue and other financial targets, as well as completing certain strategic projects in the year ending 30 June 2024. The Options are exercisable over the period of 10 years from the date of grant.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.